BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30464532)

  • 21. Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism.
    Ding Y; Gao S; Zheng J; Chen X
    Cancer Metab; 2022 Nov; 10(1):20. PubMed ID: 36447254
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Gao S; Song D; Liu Y; Yan H; Chen X
    Onco Targets Ther; 2020; 13():6339-6349. PubMed ID: 32753880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
    Guo Y; Yue P; Wang Y; Chen G; Li Y
    Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/CXCR4 axis by regulating autophagy in gastric cancer.
    Tang H; Long Q; Zhuang K; Han K; Zhang X; Guo H; Lu X
    Pathol Res Pract; 2021 Aug; 224():153532. PubMed ID: 34214844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNAi-mediated EZH2 depletion decreases MDR1 expression and sensitizes multidrug-resistant hepatocellular carcinoma cells to chemotherapy.
    Tang B; Zhang Y; Liang R; Gao Z; Sun D; Wang L
    Oncol Rep; 2013 Mar; 29(3):1037-42. PubMed ID: 23291714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition.
    Ma X; Chen H; Li L; Yang F; Wu C; Tao K
    J Exp Clin Cancer Res; 2021 Oct; 40(1):330. PubMed ID: 34666800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer.
    Huang HG; Tang XL; Huang XS; Zhou L; Hao YG; Zheng YF
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4232-4245. PubMed ID: 32373959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression and significance of the enhancer of zeste homolog 2 in lung adenocarcinoma.
    Lv Y; Yuan C; Xiao X; Wang X; Ji X; Yu H; Wu Z; Zhang J
    Oncol Rep; 2012 Jul; 28(1):147-54. PubMed ID: 22552406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil.
    Seo JS; Kim TG; Hong YS; Chen JY; Lee SK
    Arch Pharm Res; 2011 Apr; 34(4):635-43. PubMed ID: 21544729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy Facilitates Metadherin-Induced Chemotherapy Resistance Through the AMPK/ATG5 Pathway in Gastric Cancer.
    Pei G; Luo M; Ni X; Wu J; Wang S; Ma Y; Yu J
    Cell Physiol Biochem; 2018; 46(2):847-859. PubMed ID: 29635244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PLOD2 increases resistance of gastric cancer cells to 5-fluorouracil by upregulating BCRP and inhibiting apoptosis.
    Wang X; Guo J; Dai M; Wang T; Yang T; Xiao X; Tang Q; Zhang L; Jia L
    J Cancer; 2020; 11(12):3467-3475. PubMed ID: 32284742
    [No Abstract]   [Full Text] [Related]  

  • 32. Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes.
    Yang J; Lian Y; Yang R; Lian Y; Wu J; Liu J; Wang K; Xu H
    Mol Ther Nucleic Acids; 2020 Mar; 19():1164-1175. PubMed ID: 32059342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dextran Sulfate Inhibits Cell Proliferation and Induces Apoptosis by Regulating EZH2 in Gastric Carcinoma.
    Huang Y; Wang W; Xu YY; Guo J; Jiao L; Wang H; Li M; Yang Q
    Curr Cancer Drug Targets; 2021; 21(11):953-964. PubMed ID: 34551698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of PHGDH potentiates 5-FU cytotoxicity in gastric cancer cells via the Bcl-2/Bax/caspase-3 signaling pathway.
    Zhang Y; Yang L; Dai G; Cao H
    Int J Clin Exp Pathol; 2018; 11(12):5869-5876. PubMed ID: 31949673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA ZNF674-AS1 antagonizes oxaliplatin resistance of gastric cancer via regulating EZH2-mediated methylation of CHST7.
    Ye K; Wang Y
    Aging (Albany NY); 2022 Jul; 14(13):5523-5536. PubMed ID: 35802620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 38. miR-137 Modulates Human Gastric Cancer Cell Proliferation, Apoptosis, and Migration by Targeting EZH2.
    Weng XQ; Wang W
    Crit Rev Eukaryot Gene Expr; 2022; 32(4):31-40. PubMed ID: 35695663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation
    Zhang C; Kang T; Wang X; Wang J; Liu L; Zhang J; Liu X; Li R; Wang J; Zhang J
    Front Pharmacol; 2022; 13():968223. PubMed ID: 36091809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2.
    Ougolkov AV; Bilim VN; Billadeau DD
    Clin Cancer Res; 2008 Nov; 14(21):6790-6. PubMed ID: 18980972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.